Avid Bioservices Inc (CDMO)

[nuke661]

Wook,

I believe translational data has been out there for more than enough time to close the deal if it was going to be the driver. I also believe translational data has been the driver to get MSK and AZN to work with us which is great. But when it comes to icing the big deal I believe what I stated in my post; that management believes its going to take human trial validation up to at least response data in more than just a Bavi + chemo trial to get the big deal closed.

Otherwise why did management jump through so many hoops (asking for such a large share increase to ensure significantly more monies than needed to open Avid II and bring in Sunrise data, the hurry up and get the breast cancer trial and Bavi + AZN IO for NSCLC and multiple tumor types trials going ASAP) in such a short period? I still believe that management believes that the ORR data from these new trials is required to close the big deal. I also believe they base this on the feedback they are getting in their "partnering discussions" or they wouldn't spend the money to do this.

Its evident enough to me after being in this stock over 10 years now and looking at the Biotech world for the amount of time that I have, that human clinical trial data "talks" and pre-clinical data walks. Unless of course someone wants to sell on the cheap.

And by the way I've already bought mine. I'm still digging to find the large vein, screw the nuggets.